Close Menu

NEW YORK – Aspira Women's Health announced on Wednesday that it was planning a private equity financing of around $11 million.

The Austin, Texas-based firm, formerly known as Vermillion, said that investors, including affiliates of the former President and COO of Abbott Laboratories, Jack Schuler, the company's largest stockholder, had agreed to purchase approximately $11 million of unregistered shares of Aspira common stock in a private placement at a price of $3.50 per share.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Wall Street Journal, the Food and Drug Administration may soon issue an Emergency Use Authorization for convalescent plasma to treat COVID-19 patients.

Minnesota police have used genetic genealogy to make an arrest in a 1986 cold case, reports NBC News.

Researchers have used CRISPR-Cas9 to efficiently target a cephalopod pigmentation gene, as they report in Current Biology.

In Science this week: chromatin accessibility of microglia during fetal development, and more.